XTX Topco Ltd Acquires 111,128 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT)

XTX Topco Ltd increased its holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) by 178.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 173,568 shares of the company’s stock after purchasing an additional 111,128 shares during the quarter. XTX Topco Ltd owned approximately 0.15% of Applied Therapeutics worth $149,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of the business. SG Americas Securities LLC grew its stake in shares of Applied Therapeutics by 169.0% in the fourth quarter. SG Americas Securities LLC now owns 40,747 shares of the company’s stock worth $35,000 after purchasing an additional 25,601 shares during the last quarter. Intech Investment Management LLC boosted its position in Applied Therapeutics by 176.1% during the 4th quarter. Intech Investment Management LLC now owns 52,631 shares of the company’s stock valued at $45,000 after acquiring an additional 33,567 shares in the last quarter. Wellington Management Group LLP boosted its position in Applied Therapeutics by 17.8% during the 4th quarter. Wellington Management Group LLP now owns 237,850 shares of the company’s stock valued at $204,000 after acquiring an additional 35,884 shares in the last quarter. Private Advisor Group LLC bought a new stake in Applied Therapeutics during the 4th quarter valued at approximately $35,000. Finally, Hennion & Walsh Asset Management Inc. boosted its position in Applied Therapeutics by 18.1% during the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 313,355 shares of the company’s stock valued at $268,000 after acquiring an additional 47,983 shares in the last quarter. 98.31% of the stock is owned by institutional investors.

Applied Therapeutics Stock Performance

Applied Therapeutics stock opened at $0.39 on Tuesday. The stock’s 50 day simple moving average is $0.45 and its two-hundred day simple moving average is $2.68. The stock has a market cap of $55.47 million, a price-to-earnings ratio of -0.24 and a beta of 1.88. Applied Therapeutics, Inc. has a fifty-two week low of $0.30 and a fifty-two week high of $10.62.

Applied Therapeutics (NASDAQ:APLT) last posted its quarterly earnings data on Monday, April 14th. The company reported ($0.24) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.06). The business had revenue of $0.00 million during the quarter, compared to analyst estimates of $0.61 million. On average, analysts predict that Applied Therapeutics, Inc. will post -0.65 earnings per share for the current year.

About Applied Therapeutics

Applied Therapeutics, Inc, a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 (also called govorestat) that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG.